TPA within 3 hours of acute ischaemic stroke?
Dorman
P
P
Neurosciences Trials Unit, University of Edinburgh, UK.
Sandercock
P
P
D000208:Acute Disease; D002545:Brain Ischemia / Q000188:drug therapy*; D002543:Cerebral Hemorrhage / Q000139:chemically induced; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D013300:Streptokinase / Q000009:adverse effects / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000009:adverse effects / Q000379:methods*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*
D013300:Streptokinase; D010959:Tissue Plasminogen Activator